- --------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------------------
FORM 8-K
--------------------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): JUNE 30, 2005
-----------------------
MICROTEK MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
-------------------------
GEORGIA 0-24866 58-1746149
------- ------- ----------
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
13000 DEERFIELD PARKWAY, SUITE 300, ALPHARETTA, GEORGIA 30004
(Address of principal executive office) (zip code)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (678) 896-4400
(Former name or former address, if changed since last report)
-------------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
- --------------------------------------------------------------------------------
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
On June 30, 2005, the Company amended its credit agreement (the "Credit
Agreement") with JPMorgan Chase Bank to extend the maturity date of the
related revolving credit facility from June 30, 2006 to June 30, 2008,
modify the interest margin pursuant to which the interest rate on
borrowings is determined, and modify various of the financial covenants
contained in the Credit Agreement.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial Statements.
N/A
(b) Pro Forma Financial Information.
N/A
(c) Exhibits.
Exhibit
Number Description
------- -----------
10.1 Ninth Amendment Agreement dated as of June 30, 2005, to the
Amended and Restated Credit Agreement, dated as of May 14,
2001
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MICROTEK MEDICAL HOLDINGS, INC.
Date: June 30, 2005 By: /s/ Dan R. Lee
----------------------------------
Dan R. Lee, Chairman, President and
Chief Executive Officer
3
EXHIBIT INDEX
Exhibit
Number Description
- ------- -----------
10.1 Ninth Amendment Agreement dated as of June 30, 2005, to the Amended
and Restated Credit Agreement, dated as of May 14, 2001
4